Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michioki Endo

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
JAMA|June 18, 2025
CNM-Au8 in Amyotrophic Lateral SclerosisMichioki Endo, Masahiro Kami
Lancet (London, England)|February 17, 2024
Secukinumab treatment of hidradenitis suppurativa: questions remainMichioki Endo, Masahiro Kami
JAMA Oncology|October 2, 2025
Concerns Regarding Follow-Up Duration and End Point ValidityMichioki Endo, Masahiro Kami
JAMA Oncology|November 20, 2025
Details Regarding Pneumonitis With High-Dose AumolertinibMichioki Endo, Masahiro Kami
JAMA|March 27, 2024
Lepodisiran for Elevated Lipoprotein(a)Michioki Endo, Masahiro Kami
Lancet (London, England)|October 28, 2023
Bicarbonate ineffectiveness for kidney transplantMichioki Endo, Masahiro Kami
JAMA Internal Medicine|March 17, 2025
Mental Health Factors in Semaglutide DiscontinuationMichioki Endo, Masahiro Kami
JAMA Oncology|January 18, 2024
Unveiling an Overlooked Link-Promising Drug Efficacy in Lowering Withdrawal Rates in Cancer TrialsMichioki Endo, Akihiko Ozaki, Masahiro Kami
The International Journal of Health Planning and Management|February 13, 2024
Implications for the specialty board system: The struggle of young doctors in Japan's rigid healthcare frameworkYudai Kaneda, Akihiko Ozaki, Akika Ando, et al.
The International Journal of Health Planning and Management|September 1, 2024
Reassessing physician interactions with pharmaceutical companies: A response to Murayama et al. and analysis of survey discrepanciesAkihiko Ozaki, Hiroaki Saito, Michioki Endo, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
JAMA|June 18, 2025
CNM-Au8 in Amyotrophic Lateral SclerosisMichioki Endo, Masahiro Kami
Lancet (London, England)|February 17, 2024
Secukinumab treatment of hidradenitis suppurativa: questions remainMichioki Endo, Masahiro Kami
JAMA Oncology|October 2, 2025
Concerns Regarding Follow-Up Duration and End Point ValidityMichioki Endo, Masahiro Kami
JAMA Oncology|November 20, 2025
Details Regarding Pneumonitis With High-Dose AumolertinibMichioki Endo, Masahiro Kami
JAMA|March 27, 2024
Lepodisiran for Elevated Lipoprotein(a)Michioki Endo, Masahiro Kami
Lancet (London, England)|October 28, 2023
Bicarbonate ineffectiveness for kidney transplantMichioki Endo, Masahiro Kami
JAMA Internal Medicine|March 17, 2025
Mental Health Factors in Semaglutide DiscontinuationMichioki Endo, Masahiro Kami
JAMA Oncology|January 18, 2024
Unveiling an Overlooked Link-Promising Drug Efficacy in Lowering Withdrawal Rates in Cancer TrialsMichioki Endo, Akihiko Ozaki, Masahiro Kami
The International Journal of Health Planning and Management|February 13, 2024
Implications for the specialty board system: The struggle of young doctors in Japan's rigid healthcare frameworkYudai Kaneda, Akihiko Ozaki, Akika Ando, et al.
The International Journal of Health Planning and Management|September 1, 2024
Reassessing physician interactions with pharmaceutical companies: A response to Murayama et al. and analysis of survey discrepanciesAkihiko Ozaki, Hiroaki Saito, Michioki Endo, et al.
Pageof 2